Tag: Dr Kari Nadeau
Company Developing Therapy to Prevent “Allergic Cascade” Emerges from Stealth Mode
IgGenix will develop a therapy that focuses on all types of food allergies and related conditions.
Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...
Company is developing therapy to target a number of food allergies simultaneously.
Study: Antibody Injection Stops Peanut Allergy for 2 to 6 Weeks
A Stanford-led pilot study has provided early evidence that an antibody is a safe, effective and rapid food allergy treatment.
Must Hear: Interview with Stanford Immunologist Dr Kari Nadeau – Defeating...
Dr Kari Nadeau, who runs the Sean Parker Center for Allergy and Asthma Research at Stanford University, takes us on a tour of food...
Positive Mindset About Side Effects of Peanut OIT Improves Outcomes
Framing side effects as positive signs of healing significantly reduced anxiety in young children.
Enable Biosciences Awarded $224K in NIH Funding for Food Allergy Blood...
Company claims it is developing a test that detects many allergy markers at once without sacrificing quality.
Study: Drug Increases Speed and Safety of OIT for Multiple Allergies
Combining omalizumab with OIT is safe and effective for treating multiple food allergies simultaneously.
Safe + Fair to Donate 3% of Proceeds to Sean N...
Will fund research of treatments and cure for allergies and asthma.
Food Allergy Families: There's Gold in Them Thar Babies
Welcome to the birth of a billion dollar industry as companies rush to get in on the ground floor.
Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the...
We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.
